Both in Biotechnology
Liminatus Pharma vs Curis
Over the past year LIMN returned −95.6% and CRIS returned −96.2%; their daily moves had a correlation of 0.02.
LIMN −95.6% CRIS −96.2%Growth of $1, one year, split-adjusted
| Metric | LIMN | CRIS |
|---|---|---|
| Price | $2.79 | $1.11 |
| Market cap | $3.8M | $2.7M |
| Today | +0.16% | +55.48% |
| 1 month | −24.5% | +48.2% |
| 6 months | −72.7% | −91.0% |
| Year to date | −90.8% | −94.4% |
| 1 year | −95.8% | −96.3% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 0.6× |
| Net cash | — | $5.1M |
| Dividend yield | — | — |
| Volatility (60d) | 1,152.5% | 148.9% |
| Short % of float | 4.6% | 23.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).